Review launched to assess safety of type 2 diabetes medicines

A EU-wide review has been launched into medicines used to treat type 2 diabetes after more than 100 patients are thought to have developed diabetic ketoacidosis as a result of taking them

This is a free article for registered users

This article is not available as part of an institutional subscription. Why is this? You can register for free access.